Prognostic significance of early urinary catheterization after acute stroke: Secondary analyses of the international HeadPoST trial.


Journal

International journal of stroke : official journal of the International Stroke Society
ISSN: 1747-4949
Titre abrégé: Int J Stroke
Pays: United States
ID NLM: 101274068

Informations de publication

Date de publication:
02 2021
Historique:
pubmed: 23 2 2020
medline: 26 10 2021
entrez: 21 2 2020
Statut: ppublish

Résumé

An indwelling urinary catheter (IUC) is often inserted to manage bladder dysfunction, but its impact on prognosis is uncertain. We aimed to determine the association of IUC use on clinical outcomes after acute stroke in the international, multi-center, cluster crossover, Head Positioning in Acute Stroke Trial (HeadPoST). Data were analyzed on HeadPoST participants (n = 11,093) randomly allocated to the lying-flat or sitting-up head position. Binomial, logistic regression, hierarchical mixed models were used to determine associations of early insertion of IUC within seven days post-randomization and outcomes of death or disability (defined as "poor outcome," scores 3-6 on the modified Rankin scale) and any urinary tract infection at 90 days with adjustment of baseline and post-randomization management covariates. Overall, 1167 (12%) patients had an IUC, but the frequency and duration of use varied widely across patients in different regions. IUC use was more frequent in older patients, and those with vascular comorbidity, greater initial neurological impairment (on the National Institutes of Health Stroke Scale), and intracerebral hemorrhage as the underlying stroke type. IUC use was independently associated with poor outcome (adjusted odds ratio (aOR): 1.40, 95% confidence interval (CI): 1.13-1.74), but not with urinary tract infection after adjustment for antibiotic treatment and stroke severity at hospital separation (aOR: 1.13, 95% CI: 0.59-2.18). The number exposed to IUC for poor outcome was 13. IUC use is associated with a poor outcome after acute stroke. Further studies are required to inform appropriate use of IUC.

Sections du résumé

BACKGROUND
An indwelling urinary catheter (IUC) is often inserted to manage bladder dysfunction, but its impact on prognosis is uncertain. We aimed to determine the association of IUC use on clinical outcomes after acute stroke in the international, multi-center, cluster crossover, Head Positioning in Acute Stroke Trial (HeadPoST).
METHODS
Data were analyzed on HeadPoST participants (n = 11,093) randomly allocated to the lying-flat or sitting-up head position. Binomial, logistic regression, hierarchical mixed models were used to determine associations of early insertion of IUC within seven days post-randomization and outcomes of death or disability (defined as "poor outcome," scores 3-6 on the modified Rankin scale) and any urinary tract infection at 90 days with adjustment of baseline and post-randomization management covariates.
RESULTS
Overall, 1167 (12%) patients had an IUC, but the frequency and duration of use varied widely across patients in different regions. IUC use was more frequent in older patients, and those with vascular comorbidity, greater initial neurological impairment (on the National Institutes of Health Stroke Scale), and intracerebral hemorrhage as the underlying stroke type. IUC use was independently associated with poor outcome (adjusted odds ratio (aOR): 1.40, 95% confidence interval (CI): 1.13-1.74), but not with urinary tract infection after adjustment for antibiotic treatment and stroke severity at hospital separation (aOR: 1.13, 95% CI: 0.59-2.18). The number exposed to IUC for poor outcome was 13.
CONCLUSIONS
IUC use is associated with a poor outcome after acute stroke. Further studies are required to inform appropriate use of IUC.

Identifiants

pubmed: 32075569
doi: 10.1177/1747493020908140
doi:

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

200-206

Auteurs

Menglu Ouyang (M)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.
The George Institute China at Peking University Health Science Center, Beijing, China.

Laurent Billot (L)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.

Lili Song (L)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.
The George Institute China at Peking University Health Science Center, Beijing, China.

Xia Wang (X)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.

Christine Roffe (C)

Department of Neurosciences, 105646Royal Stoke University Hospital, Stoke-on-Trent, UK.

Hisatomi Arima (H)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.
Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.

Pablo M Lavados (PM)

Departmento de Neurologia and Psiquiatria, Clínica Alemana de Santiago, Servicio de Neurología, Unidad de Neurología Vascular, Vitacura, Chile.

Maree L Hackett (ML)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.
Faculty of Health and Wellbeing, University of Central Lancashire, Preston, Lancashire, UK.

Verónica V Olavarría (VV)

Departmento de Neurologia and Psiquiatria, Clínica Alemana de Santiago, Servicio de Neurología, Unidad de Neurología Vascular, Vitacura, Chile.

Paula Muñoz-Venturelli (P)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.
Center for Clinical Studies, School of Medicine-Clínica Alemana, ICIM, 28071Universidad del Desarrollo, Santiago, Chile.

Sandy Middleton (S)

Nursing Research Institute, St Vincent's Health Australia, Australian Catholic University, Sydney, Australia.

Octavio M Pontes-Neto (OM)

Stroke Service-Neurology Division, Department of Neuroscience and Behavioral Sciences, Ribeirão Preto Medical School, University of Sao Paulo, Ribeirão Preto, Brazil.

Tsong-Hai Lee (TH)

Stroke Center and Department of Neurology, Linkou Chang Gung Memorial Hospital and College of Medicine, Chang Gung University, Taoyuan.

Caroline L Watkins (CL)

Faculty of Health and Wellbeing, University of Central Lancashire, Preston, Lancashire, UK.

Thompson G Robinson (TG)

Department of Cardiovascular Sciences and NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.

Craig S Anderson (CS)

The George Institute for Global Health, Faculty of Medicine, 7800University of New South Wales, Sydney, Australia.
The George Institute China at Peking University Health Science Center, Beijing, China.
Center for Clinical Studies, School of Medicine-Clínica Alemana, ICIM, 28071Universidad del Desarrollo, Santiago, Chile.
Neurology Department, 2205Royal Prince Alfred Hospital, Sydney Health Partners, Sydney, Australia.
Heart Health Research Center, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH